Valpromide inhibits human epoxide hydrolase.
Open Access
- 1 September 1986
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 22 (3) , 269-274
- https://doi.org/10.1111/j.1365-2125.1986.tb02886.x
Abstract
The effect of antipileptic drug valpromide (VPM) on the activity of epoxide hydrolase was studied in human adult and foetal liver, kidneys, lungs, intestine and in placenta. The activity of the epoxide hydrolase was measured with both styrene oxide and benzo(a)pyrene‐4,5‐oxide as substrates. VPM inhibited the epoxide hydrolase obtained from all organs studied. The degree of inhibition was independent of the substrate used. A lowering of the epoxide hydrolase activity by 50% was observed when the concentration of VPM was similar to that of the substrates. VPM competitively inhibited the activity of adult liver epoxide hydrolase with styrene oxide as substrate.This publication has 28 references indexed in Scilit:
- VALPROMIDE/CARBAMAZEPINE AND RISK OF TERATOGENICITYThe Lancet, 1985
- Isolation of Nuclear Fractions from Human Fetal TissuesPharmacology, 1985
- Carbamazepine Metabolism in ManClinical Pharmacokinetics, 1985
- POSSIBLE HAZARD OF VALPROMIDE-CARBAMAZEPINE COMBINATION THERAPY IN EPILEPSYThe Lancet, 1984
- 5α,6α‐Epoxy‐cholestan‐3β‐ol (cholesterol α‐oxide): A specific substrate for rat liver glutathione transferase BFEBS Letters, 1982
- A study on the metabolism of dipropylacetamide to dipropylacetic acid in ratsJournal of Pharmacy and Pharmacology, 1982
- Tissue and species differences in enzymes of epoxide metabolismXenobiotica, 1981
- Dipropylacetic Acid* Plasma Levels; Diurnal Fluctuations During Chronic Treatment with DipropylacetamideTherapeutic Drug Monitoring, 1981
- Formation of Stable Epoxides in the Metabolism of Tricyclic DrugsDrug Metabolism Reviews, 1976
- Arene oxides and the NIH shift: The metabolism, toxicity and carcinogenicity of aromatic compoundsCellular and Molecular Life Sciences, 1972